Cleared Traditional

K103720 - SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS

K103720 is the FDA 510(k) clearance for SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS by Fujifilm Medical Systems U.S.A, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 85-day FDA review.

K103720 · Fujifilm Medical Systems U.S.A, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2011
Decision
85d
Days
Class 2
Risk

K103720 is an FDA 510(k) clearance for the SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical Systems U.S.A, Inc. (Stamford, US). The FDA issued a Cleared decision on March 16, 2011 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical Systems U.S.A, Inc. devices

Submission Details

510(k) Number K103720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2010
Decision Date March 16, 2011
Days to Decision 85 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 107d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1096
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K103720.
SYMBIA.NET
K110844 · Siemens Medical Solutions USA, Inc. · Apr 2011
SYNAPSE 3D LIVER ANALYSIS
K110186 · Fujifilm Medical System U.S.A., Inc. · Apr 2011
SYNGO MBF
K110494 · Siemens Medical Solutions USA, Inc. · Apr 2011
THORACIC VCAR
K103480 · Ge Medical Systems, LLC · Mar 2011
VIEWPOINT 6
K103458 · Ge Healthcare · Mar 2011
SYNAPSE 3D CEREBRAL ANALYSIS
K103687 · Fujifilm Medical System U.S.A., Inc. · Mar 2011